Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.

A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis. 2009 Jul 15; 200(2):263-72.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.